-
Cohort A RNA sequencing
Study
EGAS50000000950
-
The DIRECT study: A roadmap for ctDNA-based risk prediction, molecular profiling and MRD detection in Diffuse Large B Cell Lymphoma
Study
EGAS50000000968
-
Myeloma RNAseq
Study
EGAS00001003999
-
cell-free Methylated DNA by Immunoprecipitation and Sequencing (cfMeDIP) of human meningioma samples.
Study
EGAS50000001539
-
RNA-seq of murine osteosarcoma cell line genetically modified for CYR61
Study
EGAS50000000526
-
WNT7B-reporter organoids sorted
Study
EGAS50000001543
-
PDAC organoids treated with LGK974
Study
EGAS50000001542
-
Bleomycin Induced Pneumonitis cohort of the Exceptional Responders Program of the Garvan Institute of Medical Research
Study
EGAS50000001545
-
Cellular Analysis of Resistance and Evolution (CARE) IDH-mutant glioma dataset
Study
EGAS50000001727
-
Rare Germline Variants in CDKN2A-Negative Children and Adolescents with Cutaneous Melanoma
Study
EGAS50000001311
-
The mutational landscape and its longitudinal dynamics in relapsed and refractory Hodgkin lymphoma
Study
EGAS50000000149
-
Molecular classification of small intestinal adenocarcinomas
Study
EGAS50000001238
-
Chromatin accessibility of clear cell renal cell carcinoma
Study
EGAS50000001325
-
ChIP-seq data in MSC_Pat and EWIma1 (FLI1 & H3K27ac)
Study
EGAS50000001172
-
A prospective multicenter study of plasma ctDNA versus archival tumor tissue to guide FGFR-targeted therapy in metastatic urothelial cancer - Targeted
Study
EGAS50000001450
-
Raw sequencing of single-cell RNA-seq data of a phase II clinical trial (NCT03419481)
Study
EGAS50000001315
-
RNAseq of preneoplasia lung adenocarcinoma
Study
EGAS50000000271
-
Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma
Study
EGAS50000001318
-
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy
Study
EGAS50000001080
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - WGS
Study
EGAS50000001082
-
ERBB2/HER2 alterations in ctDNA and metachronous tissues of patients with metastatic urothelial cancer - Targeted
Study
EGAS50000001081
-
Whole genome sequencing of preneoplasia lung adenocarcinoma
Study
EGAS50000000272
-
Gene expression analysis of clear cell renal cell carcinoma
Study
EGAS50000001324
-
3D chromatin analysis of clear cell renal cell carcinoma using micro-C
Study
EGAS50000001323
-
ChIP-seq analysis of clear cell renal cell carcinoma
Study
EGAS50000001322
-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by targeted sequencing
Study
EGAS50000001327
-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by shallow whole genome sequencing
Study
EGAS50000001328
-
Identification of New Therapeutic Targets for Renal Medullary Carcinoma via Integrated Genomic and Transcriptomic Profiling
Study
EGAS50000001280
-
Neuroblastoma Smart-Seq2 Single Nuclei Sequencing Data
Study
EGAS50000001103
-
Transcriptomic analysis of B-cell acute lymphoblastic leukaemia (B-ALL) patients treated on the ALL09 clinical trial
Study
EGAS50000001109
-
Sequence data to study genomic CNVs that drive apoptotic resistance and relapses on immune checkpoint inhibitors
Study
EGAS50000001055
-
3' mRNA- sequencing bams
Study
EGAS50000000242
-
Delineation of the heterogeneous molecular landscape of HRS cells and their biological contributions to forming comprehensive TME ecosystems.
Study
EGAS00001008064
-
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Study
EGAS00001007527
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
Whole exome sequencing of preneoplasia lung adenocarcinoma
Study
EGAS50000000270
-
Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer
Study
EGAS00001007716
-
Whole exome sequencing of pediatric soft tissue sarcoma PDX models
Study
EGAS50000000048
-
Whole exome sequencing data of patients with resectable esophageal adenocarcinoma treated with neoadjuvant atezolizumab and chemoradiation (PERFECT)
Study
EGAS00001006504
-
Efficacy of two different FGFR-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation
Study
EGAS50000000015
-
Aberrant EZHIP Expression Drives Tumorigenesis in Osteosarcoma
Study
EGAS00001007531
-
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Study
EGAS50000000838
-
Whole exome sequencing of Ewing and CIC-DUX4 sarcoma tumoroid models
Study
EGAS50000000379
-
RNA sequencing of Ewing and CIC-DUX4 sarcoma tumoroid models
Study
EGAS50000000380
-
Whole-exome sequencing data of ovarian clear cell carcinoma in East Asia
Study
EGAS50000000031
-
Single-Cell RNA-seq of Primary High Grade Serous Carcinoma
Study
EGAS50000000068
-
Single-cell profiling reveals mechanisms of response to anti-PD-L1 versus anti-PD-L1 combined with anti-CTLA4 in head and neck squamous cell carcinoma
Study
EGAS50000000037
-
Origination of Ovarian Cancer is Dependent on Specific Aneuploidy Landscape
Study
EGAS00001007220
-
Epigenomic dataset of Human Hepatocellular Carcinoma for EpiHK
Study
EGAS50000000039
-
Identification of germline variants in Medullary thyroid carcinoma (MTC) by whole- exome sequencing
Study
EGAS50000000061